Inactive Instrument

Analyst Reco. INC Research Holdings Inc Nasdaq

Equities

US45329R1095

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mizuho Securities Adjusts Syneos Health Price Target to $43 From $38, Maintains Neutral Rating	23-05-16	MT
Evercore ISI Raises Syneos Health's Price Target to $43 From $38, In Line Rating Kept	23-05-11	MT
JPMorgan Upgrades Syneos Health to Neutral From Underweight, Raises Price Target to $43 From $28	23-05-11	MT
Jefferies Raises Syneos Health's Price Target to $43 From $38, Hold Rating Kept	23-05-11	MT
Morningstar Downgrades Syneos Health to Hold From Buy, Cuts Price Target to $43 From $55	23-05-11	MT
Deutsche Bank Downgrades Syneos Health to Hold From Buy, Adjusts Price Target to $43 From $51	23-05-11	MT
UBS Adjusts Syneos Health Price Target to $43 From $40, Maintains Neutral Rating	23-05-11	MT
Barclays Upgrades Syneos Health to Equalweight From Underweight, Adjusts Price Target to $43 From $37	23-05-11	MT
Baird Downgrades Syneos Health to Neutral From Outperform, Price Target is $43	23-05-11	MT
Barclays Adjusts Syneos Health Price Target to $37 From $45, Maintains Underweight Rating	23-04-04	MT
Barclays Adjusts Price Target on Syneos Health to $45 From $30, Maintains Underweight Rating	23-03-01	MT
UBS Adjusts Syneos Health's Price Target to $40 From $34, Maintains Neutral Rating	23-02-27	MT
Baird Adjusts Price Target on Syneos Health to $51 From $42, Maintains Outperform Rating	23-02-17	MT
JPMorgan Downgrades Syneos Health to Underweight From Neutral, Adjusts Price Target to $28 From $30	23-02-13	MT
Barclays Downgrades Syneos Health to Underweight From Overweight, Price target is $25	23-01-13	MT
Mizuho Downgrades Syneos Health to Neutral From Buy, Slashes Price Target to $38 From $66	22-12-14	MT
Deutsche Bank Adjusts Syneos Health Price Target to $51 From $77, Maintains Buy Rating	22-11-09	MT
UBS Adjusts Syneos Health Price Target to $34 From $68, Maintains Neutral Rating	22-11-08	MT
Baird Adjusts Price Target on Syneos Health to $42 From $80, Maintains Outperform Rating	22-11-07	MT
Citigroup Adjusts Price Target on Syneos Health to $30 From $55, Maintains Neutral Rating	22-11-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. INC Research Holdings Inc Nasdaq

Equities

US45329R1095

Analyst Reco.

Filters